SPHK1 and cancer: Due to the obvious statistical heterogeneity (I2 = 57.3%, P = 0.009), the random model was applied and a significant association was observed between increased SPHK1 expression and poor DFS of cancer patients (HR = 1.34, 95% CI: 1.13-1.59, P = 0.001) (Figure 3).